Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 5/20 | 0.49 |
| ▸ | RAB9A | P51151 | 3/20 | 0.49 |
| ▸ | TP53 | P04637 | 2/20 | 0.49 |
| ▸ | NPC1 | O15118 | 2/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.49 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.49 |
| ▸ | HPGD | P15428 | 2/20 | 0.46 |
| ▸ | POLB | P06746 | 1/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.43 |
| ▸ | GLA | P06280 | 1/20 | 0.43 |
| ▸ | CSNK2A2 | P19784 | 1/20 | 0.42 |
| ▸ | CSNK2A1 | P68400 | 1/20 | 0.42 |
| ▸ | TUBB4A | P04350 | 1/20 | 0.42 |
| ▸ | TUBB | P07437 | 1/20 | 0.42 |
| ▸ | TUBA3C | P0DPH7 | 1/20 | 0.42 |
| ▸ | TUBA1B | P68363 | 1/20 | 0.42 |
| ▸ | TUBA4A | P68366 | 1/20 | 0.42 |
| ▸ | TUBB4B | P68371 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3366859 | 0.94 | SMN1; SMN2 (0.46) | SMN1; SMN2RAB9ATP53NPC1ALDH1A1 | |
| SCHEMBL3365339 | 0.94 | SMN1; SMN2 (0.46) | SMN1; SMN2RAB9ATP53NPC1ALDH1A1 | |
| SCHEMBL994563 | 0.88 | RAB9A (0.55) | SMN1; SMN2RAB9ANPC1ALDH1A1MAPK1 | |
| SCHEMBL3368672 | 0.85 | EPHX1 (0.59) | RAB9AALDH1A1CSNK2A2CSNK2A1L3MBTL1 | |
| SCHEMBL2903601 | 0.83 | RAB9A (0.51) | SMN1; SMN2RAB9ANPC1ALDH1A1MAPK1 | |
| SCHEMBL2906397 | 0.83 | RAB9A (0.51) | SMN1; SMN2RAB9ANPC1ALDH1A1MAPK1 | |
| SCHEMBL6675218 | 0.83 | TSHR (0.56) | SMN1; SMN2RAB9ANPC1ALDH1A1MAPK1 | |
| SCHEMBL3363746 | 0.83 | KMT2A (0.53) | SMN1; SMN2RAB9ANPC1ALDH1A1HPGD | |
| SCHEMBL6578691 | 0.82 | TSHR (0.51) | SMN1; SMN2RAB9ANPC1ALDH1A1MAPK1 | |
| SCHEMBL3369754 | 0.81 | EPHX1 (0.54) | RAB9ANPC1ALDH1A1CSNK2A2CSNK2A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1440065-B1 | METHOD FOR PREPARING ALKOXYCARBONYLAMINO-TRIAZINES | BASF SE (DE) | 2010-10-06 | — | — | EP | disclosed |
| US-7371856-B2 | Preparation of alkoxycarbonylaminotriazines | BASF AKTIENGESELLSCHAFT (DE) | 2008-05-13 | — | — | US | disclosed |
| US-20070083047-A1 | Preparation of Alkoxycarbonylaminotriazines | BASF AKTIENGESELLSCHAFT (DE) | 2007-04-12 | — | — | US | disclosed |
| US-7169923-B2 | Method for preparing alkoxycarbonylamino-triazines | BASF AKTIENGESELLSCHAFT (DE) | 2007-01-30 | — | — | US | disclosed |
| US-20040249149-A1 | Method for preparing alkoxycarbonylamino-triazines | BASF AKTIENGESELLSCHAFT (DE) | 2004-12-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040249149-A1 | Method for preparing alkoxycarbonylamino-triazines | ADH1C, PNMT, TET2 | SMN1; SMN2 2328/4885RAB9A 4268/4885TP53 4201/4885 |
| US-20070083047-A1 | Preparation of Alkoxycarbonylaminotriazines | ADH1C, TET2, PNMT | SMN1; SMN2 2648/4885RAB9A 3671/4885TP53 4506/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.